SPharm Regulatory milestones through the years.

Follow some of SPharm regulatory milestones on the way to becoming one of the leading drug and health product regulatory firms in Canada.

1997

FOUNDING OF SPHARM

SPharm is founded as a consultancy in the drug regulatory industry in Canada.
1997
2002

CONTINUED GROWTH

Company continues to grow, hiring more staff members and expanding to other categories of health products.
2002
2006

COMPANY OF THE YEAR AWARD

Receives Chamber of Commerce award: "Company of the year".
2006
2008

NEW BUILDING, MORE GROWTH

Company continues its growth and purchases its own building to establish a larger HQ.
2008
2008

APPROVAL IN CANADA FIRST

SPharm continues to push boundaries as it helps Health companies get Drug Approval in Canada BEFORE they get approvals in any other market (USA, Europe).
2008
2008

BUILDING AN APPEALS EXPERTISE

Successfully defended its third administrative appeal at Health Canada. When a Notice of non-compliance or a License refusal is received from Health Canada, that decision can be appealed through an administrative process. SPharm ultimately received approvals for its clients after the appeals.
2008
2014

RECOGNIZED AS AN EXPERT WITNESS

SPharm founder, Susanne Picard, is called upon as a subject matter expert for Pharmacy litigations.
2014
2015

RARE DISEASE DEVELOPMENT

Contributed to a rare disease drug development from conception to Health Canada approval in less than 4 years.
2015
2016

MORE GROWTH, MORE STAFF HIRES

As the company continues to grow, more staff is hired to meet continued demand and improve operational effectiveness.
2016
2017/2018

IMPLEMENT INTERNALLY eCTD SUBMISSIONS

Company implements CTA and other submission types in eCTD format in Canada and worldwide. SPharm does this work internally for clients, as it is more efficient than coordinating with a third party.
2017/2018
2019

OVER 100 CTA SUBMISSIONS IN A YEAR

Reached an impressive +100 CTAs/CTA - Amendments submissions in a single year.
2019
2019

OVER 210 SUBMISSIONS IN A YEAR

Company reached a new record of over 210 total submissions in that year. Includes Clinical Trial Applications, New Drug Submissions, Medical Device License Applications, Abbreviated New Drug Submissions, DIN applications, Lifecycle management submissions, among others.
2019
2022

25 YEARS OF REGULATORY EXCELLENCE

The SPharm team proudly celebrates a quarter of a century delivering exceptional health product regulatory services to pharmaceutical and biotech companies worldwide.

Please read SPharm 25th Anniversary Press Release
2022
2024

NEW OWNERSHIP AT SPHARM

After years on the management team alongside former owner Susanne Picard, Marie-Claude Gravel and Krystel Bisson became the new owners of SPharm as of May 2024
2024

Track Record of Success

NUMBER OF SUBMISSIONS

Over 1500 submissions in the past 10 years

SUBMISSION SUCCESS RATE

Near 99%

CLIENT LOCATIONS

SPharm has delivered regulatory services to clients in 15 different countries

A Key Factor in Our Clients' Success

“SPharm truly are Canada’s Drug Regulatory Experts! An exceptional team, lean and efficient with 100% understanding of Health Canada. They are the perfect partner in their field, seamless, proactive, prompt! We’ve worked with them for over 20 years and when I meet with sponsors, I openly recommend SPharm for any regulatory needs in Canada.”
Julie Martin
CEO and Co-owner, Scimega
“The opportunity to work with Susanne and SPharm for over 20 years testifies to the quality of work and the relationship one experiences with the SPharm team. They became an extension of our own, our success enriching our relationship over the course of business in parallel with a great friendship.”
Jean De Serres, MD, M.Sc, MBA, I.As,
VP Scientific Affairs and Operations, Paladin Labs
“We have had the pleasure of working with SPharm since the inception of our company, and since then SPharm has consistently exceeded our expectations in terms of service, timeliness, and deliverables. They have been a key factor in the success of our pharmaceutical company.”
Robert Vinson, Ph.D.
Chief Innovation Officer, Searchlight Pharma Inc.

Find out what SPharm Regulatory Consultants can do for you.

Learn how our proven expertise can help reach your objectives faster. Contact us today.